Among large firms covering GLP-1 agonists for weight loss, share requiring lifestyle or clinical support, by firm size, 2025
Note: Firms with multiple plans were asked about their plan with the largest enrollment. Among firms with 200 or more workers that offer health benefits, 19% reported that their largest plan included coverage for any GLP-1 inhibitor drugs when used primarily for weight loss. Clinical support includes meeting with a dietitian, case manager, therapist, or participating in a lifestyle program.
